Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Kirin's TPO enters phase II in several Asian countries

Sep. 15, 1997

Cannabinoid receptor ligand shows synergistic hematopoietic effects in vitro

Sep. 12, 1997

Kampo medicine with hypolipidemic and antiatherosclerotic effects

Sep. 12, 1997

Focus on diabetes research in the U.S.

Sep. 12, 1997

Oxygent enhances oxygenation more effectively than blood in surgical patients

Sep. 11, 1997

SKB patents several series of vitronectin receptor antagonists

Sep. 11, 1997

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Sep. 10, 1997

PolyHeme blood substitute advances to phase III

Sep. 10, 1997

Osteoprotegerin: new polypeptide for bone diseases

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...